LONG-ACTING BETA2-AGONISTS VERSUS LEUKOTRIENE RECEPTOR ANTAGONIST AS ADD-ON THERAPY TO CORTICOSTEROIDS FOR CHRONIC ASTHMA MANAGEMENT IN PATIENTS OF KARACHI, PAKISTAN
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2014, Vol 5, Issue 2
Abstract
Asthmatic patients are usually maintained with inhaled corticosteroids but if symptoms are appearing we need to manage asthma with add on therapy either with LABA or leukotriene receptor antagonist. To estimate which maintenance therapy is more effective among LABA with CS or LTRA with CS and which combination is more prescribed in asthmatic patients of Karachi. We take 20 asthmatic patients from diff hospitals of karachi and find out the no of patients were taking corticosteroids mono therapy. Corticosteroids with long acting beta two agonist, corticosteroids with leukotriene receptor antagonist for long term management of asthma. Out of 20 patients 2 patients were the age of below 6 years and all are receiving corticosteroids for maintenance, 5 patients come in the age group of 6- 12 years and among them 1 patient was receiving corticosteroid mono therapy for maintenance, 1 patient was receiving combination of LABA with corticosteroid and 3 patient were receiving combination of LTRA’s with corticosteroids and the adult patients i.e. of age above 12, receiving corticosteroid combination with montelukast. Asthmatic patients are usually maintained with corticosteroids, if not maintained than add on therapy is started LABA should be added with corticosteroid but if the symptoms still continued after giving LABA then LTRA should be started but according to our result LTRA is more prescribed as maintenance therapy because of severe side effects associated with LABA. However LTRA is less effective than LABA but it is safe for long tern maintenance and can be give prophylactically to prevent from asthmatic symptoms.
Authors and Affiliations
Safila Naveed, Safa Akmal , Sameea Zubair
Keywords
Related Articles
- EP ID EP120959
- DOI 10.7897/2230-8407.050208
- Views 82
- Downloads 0
REVIEW ON HERBAL PLANTS USEFUL IN TUBERCULOSIS
The Anti-Tuberculosis (Anti- TB) drugs are less effective because of emergence of Multi-Drug Resistance (MDR) and extensively Drug Resistant (XDR) strains of M. Tuberculosis. Anti-TB allopathic drugs also results into si...
OLD AND NEW EMERGING THEREPIES FOR MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an autoimmune disease that is characterized by central nervous system inflammation, demyelination, and axon loss. It’s affect up to two million people world wide and represents a prime cause of...
SYNTHESIS CHARACTERIZATION AND PHARMACOLOGICAL ACTIVITY OF NOVEL THIADIAZOLE ANALOGUES
A new series of Thiadiazole showed diversified pharmacological activities. In view of potential biological activities of Thiadiazole, it was considered worth will to synthesized2-Benzylidenylamino-5-(N—bezotriozolomethyl...
GLYCOGEN SYNTHASE KINASE 3Β PREDICTION AS PRIMARY CELLULAR TARGET TO MEDIATE ANTI-HEPATITIS C EFFECT OF NITAZOXANIDE
Hepatitis C is a major healthcare problem that launched the quest and the interest of scientists to search for solutions that alleviate its risks. New groups of drugs are developed and repurposed for this reason. One of...
PHARMACOGNOSTIC AND PHYTOCHEMICAL STUDY OF CHLOROPHYTUM LAXUM R. BR.
Chlorophytum laxum R. Br. belongs to family Liliaceae and is being used in the indigenous systems of medicine as a galactogogue and aphrodisiac. It is being sold in the market under the common name “safed musali”. The wh...